Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins
Year: 2025
Type: article
Language: en
Topic: SARS-CoV-2 and COVID-19 Research
Authors and affiliations:
raw_author_name: Peter J. Halfmann
raw_affiliation_strings: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA
raw_author_name: Raj S. Patel
raw_affiliation_strings: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
raw_author_name: Augustine Duffy
raw_affiliation_strings: School of Chemical & Biomolecular Engineering, Georgia Institute of Technology,, Atlanta, GA, USA
raw_author_name: Tong Wang
raw_affiliation_strings: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA
raw_author_name: Atsuhiro Yasuhara
raw_affiliation_strings: Drukier Institute for Children's Health, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA
raw_author_name: Kayla Carneal
raw_affiliation_strings: School of Chemical & Biomolecular Engineering, Georgia Institute of Technology,, Atlanta, GA, USA
raw_author_name: Annika Singh
raw_affiliation_strings: College of Sciences, Georgia Institute of Technology, Atlanta, GA, USA
raw_author_name: Carmen Rai
raw_affiliation_strings: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
raw_author_name: Patrick C. Wilson
raw_affiliation_strings: Drukier Institute for Children's Health, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA
raw_author_name: Yoshihiro Kawaoka
raw_affiliation_strings: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan. yoshihiro.kawaoka@wisc.edu
Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA. yoshihiro.kawaoka@wisc.edu
Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), University of Tokyo, Tokyo, Japan. yoshihiro.kawaoka@wisc.edu
The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan. yoshihiro.kawaoka@wisc.edu
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan
Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), University of Tokyo, Tokyo, Japan
raw_author_name: Ravi S. Kane
raw_affiliation_strings: School of Chemical & Biomolecular Engineering, Georgia Institute of Technology,, Atlanta, GA, USA. ravi.kane@chbe.gatech.edu
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA. ravi.kane@chbe.gatech.edu
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
School of Chemical & Biomolecular Engineering, Georgia Institute of Technology,, Atlanta, GA, USA